BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17729157)

  • 21. [Inhibitory effect of lidamycin upon vasculogenic mimicry and its induction of apoptosis in glioma cells].
    Li XQ; Zhang SH; Ouyang ZG; Zhen YS
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1736-40. PubMed ID: 19862975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors.
    Gilg AG; Tye SL; Tolliver LB; Wheeler WG; Visconti RP; Duncan JD; Kostova FV; Bolds LN; Toole BP; Maria BL
    Clin Cancer Res; 2008 Mar; 14(6):1804-13. PubMed ID: 18347183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothermic modulation of doxorubicin, cisplatin and radiation cytotoxicity in vitro.
    Lundgren-Eriksson L; Hultborn R; Henriksson R
    Anticancer Res; 2001; 21(5):3275-80. PubMed ID: 11848483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of simulated microgravity on proliferation and chemosensitivity in malignant glioma cells.
    Takeda M; Magaki T; Okazaki T; Kawahara Y; Manabe T; Yuge L; Kurisu K
    Neurosci Lett; 2009 Sep; 463(1):54-9. PubMed ID: 19628020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo.
    Altinoz MA; Nalbantoglu J; Ozpinar A; Emin Ozcan M; Del Maestro RF; Elmaci I
    Clin Neurol Neurosurg; 2018 Oct; 173():20-30. PubMed ID: 30055402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of cytotoxicity of turbinamide in vitro.
    Esposito G; Aiello A; Carbonelli S; Menna M; Fattorusso E; Iuvone T
    Anticancer Res; 2002; 22(5):2827-31. PubMed ID: 12530004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cisplatin-irradiation combination suggests that apoptosis is not a major determinant of clonogenic death.
    Lo Nigro C; Arnolfo E; Taricco E; Fruttero A; Russi EG; Lucio F; Ribero S; Comino A; Merlano M; Ungari S
    Anticancer Drugs; 2007 Jul; 18(6):659-67. PubMed ID: 17762394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenyl-tert-butylnitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model.
    Doblas S; Saunders D; Kshirsagar P; Pye Q; Oblander J; Gordon B; Kosanke S; Floyd RA; Towner RA
    Free Radic Biol Med; 2008 Jan; 44(1):63-72. PubMed ID: 18045548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
    Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
    Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells.
    Tiwari M; Bajpai VK; Sahasrabuddhe AA; Kumar A; Sinha RA; Behari S; Godbole MM
    Carcinogenesis; 2008 Mar; 29(3):600-9. PubMed ID: 18174255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibition and chemosensitization of exogenous nitric oxide released from NONOates in glioma cells in vitro.
    Weyerbrock A; Baumer B; Papazoglou A
    J Neurosurg; 2009 Jan; 110(1):128-36. PubMed ID: 18991497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential antiglioma activity of 9-hydroxy-2-N-methylellipticine as determined by pharmacological and human tumor clonogenic cell studies.
    Ali-Osman F; Rosenblum ML; Giannini DD; Levin VA
    Cancer Res; 1985 Jul; 45(7):2988-92. PubMed ID: 4005838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
    Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
    Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
    Seeger H; Wallwiener D; Mueck AO
    Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of in vitro and in vivo anticancer activities of polysaccharide peptide from Grifola frondosa by chemical modifications.
    Chan JY; Chan E; Chan SW; Sze SY; Chan MF; Tsui SH; Leung KY; Chan RY; Chung IY
    Pharm Biol; 2011 Nov; 49(11):1114-20. PubMed ID: 21595572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
    Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
    J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranuclear microtubules are hallmarks of an unusual form of cell death in cisplatin-treated C6 glioma cells.
    Krajcí D; Mares V; Lisá V; Bottone MG; Pellicciari C
    Histochem Cell Biol; 2006 Jan; 125(1-2):183-91. PubMed ID: 16283354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
    Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M
    Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase-contrast microscopy studies of early cisplatin-induced morphological changes of malignant mesothelioma cells and the correspondence to induced apoptosis.
    Janson V; Behnam-Motlagh P; Henriksson R; Hörstedt P; Engström KG; Grankvist K
    Exp Lung Res; 2008 Feb; 34(2):49-67. PubMed ID: 18266129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of lipoplatin in tumor and in normal cells in vitro.
    Arienti C; Tesei A; Ravaioli A; Ratta M; Carloni S; Mangianti S; Ulivi P; Nicoletti S; Amadori D; Zoli W
    Anticancer Drugs; 2008 Nov; 19(10):983-90. PubMed ID: 18827563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.